CBD

How does CBD oil affect the human body, and what effects are scientifically proven?

Wie wirkt CBD Öl auf den menschlichen Körper und welche Effekte sind wissenschaftlich belegt?
Cannabis Expert at CANNANA

Maryna K.

Maryna K. has been working with cannabis, CBD, and hemp products for many years. Part of CANNANA since its founding, she now serves as an author and editorial lead dedicated to providing well-founded information, current insights, and breaking down prejudices surrounding cannabis.

All articles by Maryna K.

CBD oil can influence various signaling pathways in the human body. Scientifically, the effect of highly pure, prescription cannabidiol on certain rare forms of epilepsy has been clearly proven. While there are research approaches for frequently advertised effects on sleep problems, stress, anxiety, pain, or inflammation, there is no comparable robust evidence yet.

The product type is also crucial: an approved CBD medicine is not equivalent to a freely available CBD oil, a cosmetic product, or an aromatic oil. Differences exist, among other things, in purity, dosage, application, quality control, and medical supervision.

Table of Contents

  1. How does CBD affect the human body?
  2. What CBD effects are proven for epilepsy?
  3. How well is the effect of CBD on anxiety and stress studied?
  4. Is CBD oil scientifically proven to help with sleep?
  5. Is an effect of CBD against pain proven?
  6. What side effects and interactions can CBD cause?
  7. Why do CBD oils differ in their effects?
  8. How can CBD studies be properly classified?

How does CBD affect the human body?

CBD does not act as a strong activator of the CB1 receptor like THC and therefore usually does not cause a typical cannabis high. Instead, cannabidiol indirectly influences several receptors, enzymes, and neurotransmitter systems. These include signaling pathways involved in nerve signal processing, stress responses, pain perception, and inflammatory processes.

However, the exact mechanism of action is not fully understood. Even for the proven use against certain epileptic seizures, the European Medicines Agency assumes that CBD could influence, among other things, calcium transport in nerve cells and the adenosine system. A simple statement like "CBD activates the endocannabinoid system" therefore only incompletely describes the actual processes.

Practical classification: The fact that CBD interacts with a biological signaling pathway does not yet prove a therapeutic effect. Controlled human studies are required for scientific proof of efficacy.

What CBD effects are proven for epilepsy?

The strongest clinical evidence exists for high-purity cannabidiol in certain rare forms of epilepsy. The prescription drug Epidyolex is approved in the European Union for seizures in Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis.

According to the EMA, five key studies examined more than 900 patients. In Lennox-Gastaut syndrome, the number of certain drop seizures decreased by up to 64 percent with CBD and clobazam, compared to up to 31 percent with placebo and clobazam. In tuberous sclerosis, the reduction in seizures at the highest tested dose was 49 percent, compared to 27 percent with placebo.

These results cannot be transferred to commercially available CBD oils. In medical treatment, standardized solutions with precisely defined dosages of several milligrams per kilogram of body weight are used. Therapy is medically supervised and includes, among other things, monitoring of liver values.

How well is the effect of CBD on anxiety and stress studied?

CBD shows a possible anxiolytic effect in individual experimental studies, but the results are not uniform. In a study with a simulated public speech, a single dose of 300 mg CBD reduced certain anxiety scores compared to placebo. Other tested dosages showed no comparable effect.

Another randomized study on test anxiety, however, found no significant effect of CBD on general anxiety or the specific test situation.

The research thus provides a possible signal, but not yet proof that freely available CBD oil effectively treats an anxiety disorder. Furthermore, the dosages studied were often significantly higher than the amounts taken with a few drops of a consumer product.

Is CBD oil scientifically proven to help with sleep?

A reliable sleep-promoting effect of pure CBD has not yet been proven. Many studies on cannabis and sleep use mixtures of CBD and THC. Improvements in such studies therefore cannot be clearly attributed to cannabidiol.

In a controlled study with 293 people, CBN alone and CBN in combination with 10, 20, or 100 mg CBD were investigated. The additional administration of CBD did not improve the effect of CBN on sleep quality. No clear advantage was also shown in terms of sleep onset latency and nocturnal wakefulness.

An evaluation of clinical studies on low CBD dosages rated the results for sleep problems as small and inconsistent. Larger, longer-term studies with pure CBD are still needed.

Is an effect of CBD against pain proven?

For CBD alone, there is currently no sufficient evidence of reliable pain relief. Positive statements about cannabinoids in chronic pain are often based on studies with THC or combinations of THC and CBD. These results cannot be automatically transferred to pure CBD.

In a randomized, double-blind study, people with painful hand osteoarthritis or psoriatic arthritis received 20 to 30 mg of CBD daily or a placebo for twelve weeks. A significant pain reduction occurred in 22 percent of the CBD group and in 21 percent of the placebo group. The difference was neither clinically nor statistically significant. No clear advantage was also shown in terms of sleep, anxiety, and depressive symptoms.

Anti-inflammatory effects were primarily observed in cell cultures and animal models. Such results help in the development of new research questions but are not yet proof of an anti-inflammatory effect of a CBD oil in humans.

What side effects and interactions can CBD cause?

CBD can cause side effects, although cannabidiol does not cause a typical high. For the approved drug, drowsiness, decreased appetite, diarrhea, fatigue, vomiting, and elevated liver enzymes are among the known adverse effects.

A 2025 FDA evaluation of a randomized study examined 201 healthy adults. Participants received approximately 250 to 550 mg of CBD daily for four weeks. In 5.6 percent of the CBD group, the liver enzyme ALT rose to more than three times the upper normal limit; this finding did not occur in the placebo group. The changes caused no recognizable symptoms and normalized after discontinuation. The study does not prove that low CBD amounts have the same risk, but it shows the importance of dose and liver tolerance.

CBD can also affect the processing of other active ingredients in the liver. This can make medications stronger or weaker. Particular caution is required, among other things, with regularly taken medications, liver diseases, pregnancy, and breastfeeding.

In 2026, the EFSA set a provisional safe intake level of 0.0275 mg per kilogram of body weight per day for certain CBD food supplements with at least 98 percent purity. This corresponds to approximately 2 mg of CBD per day for a person weighing 70 kg. For individuals under 25, pregnant women, breastfeeding women, and people taking medication, the EFSA could not establish safety. This value is a cautious safety assessment and not a therapeutic dosage recommendation.

Why do CBD oils differ in their effects?

CBD oil is not a uniform product category. Medicines, food supplements, cosmetic products, and aromatic oils are subject to different requirements. Therefore, not only the percentage on the label but also the actual composition is crucial.

The Federal Institute for Risk Assessment examined 26 cannabinoid oils. Manufacturers declared contents between 2.5 and 20 percent, while values between 3 and 24 percent were measured in the laboratory. THC was found in 20 of the 26 samples.

At the daily amount recommended by the manufacturer, the THC concentration in half of the examined products would have been sufficient to exceed the acute reference dose for THC set by the EFSA. This does not automatically mean that an intoxicating effect occurs, but it illustrates the differences between product declaration and actual composition.

Practical recommendation: Product category, intended use, batch number, and current laboratory analysis should be checked before use. A product for external use must not be taken orally on its own.

How can CBD studies be properly classified?

A reliable CBD study should answer four questions:

  1. Was CBD studied in humans or only in animals and cells?
  2. Did the preparation contain exclusively CBD or additionally THC, CBN, and other cannabinoids?
  3. What CBD dose was used?
  4. Was it a standardized medicine or a commercially available oil?

Dosage is particularly important. An effect after a single dose of 300 mg CBD does not mean that a few milligrams will produce the same effect. Similarly, an effect of a THC-CBD preparation cannot be automatically attributed to CBD alone.

Conclusion: What effects of CBD oil are actually proven?

CBD influences several biological signaling pathways, but the number of clearly proven medical effects remains limited. The effect of highly pure medicinal CBD in certain rare forms of epilepsy is well-established. For anxiety and stress, there are initial but contradictory indications. For sleep problems, pain, and inflammation, the clinical evidence is not yet sufficient to confirm a reliable effect of commercially available CBD oils.

CBD is also not automatically free of side effects. Dosage, product quality, drug interactions, and liver tolerance must be considered. Reputable information therefore clearly distinguishes between research potential, medically proven effects, and general well-being.

You can find more background information in our guides on cannabis oil, hemp oil, and CBD oil, on the difference between CBD and THC, and on full-spectrum CBD and CBD isolate.

Sources and References 8

Scientific references, official statements, and legal frameworks for this article:

  1. EFSA: Vorläufige Sicherheitsbewertung von Cannabidiol (CBD) als neuartiges Lebensmittel Official Authority
    Europäische Behörde für Lebensmittelsicherheit (EFSA)(2026)— Festlegung eines vorläufigen sicheren Aufnahmewertes von 0,0275 mg/kg KG/Tag für CBD-Erzeugnisse mit ≥98 % Reinheit.
  2. FDA: CDER Investigators Address the Safety of CBD in a Randomized Trial Official Authority
    U.S. Food and Drug Administration (FDA)(2025)— Klinische Untersuchung zu Leberenzymen (ALT) und endokrinen Parametern bei gesunden Erwachsenen unter täglicher CBD-Einnahme.
  3. BfR: Cannabinoide in CBD-Ölen – wie viel ist enthalten? Official Authority
    Bundesinstitut für Risikobewertung (BfR)(2024)— BfR-Mitteilung Nr. 035/2024; Laboranalyse von 26 frei verkäuflichen Cannabinoid-Ölen bezüglich Wirkstoffgehalt und THC-Spuren.
  4. WHO: Cannabidiol (CBD) Critical Review Report Official Authority
    Weltgesundheitsorganisation (WHO)(2018)— Expert Committee on Drug Dependence (ECDD), 40. Sitzung; Toxikologische und pharmakologische Gesamtbewertung von reinem CBD.
  5. Studie: Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test Study
    Brazilian Journal of Psychiatry / PubMed (PMID: 30328956)(2019)— Doppelblinde, placebokontrollierte Studie zu angstlösenden Effekten unterschiedlicher CBD-Dosierungen (150, 300, 600 mg).
  6. Studie: A double-blind, randomized, placebo-controlled study of the safety and effects of CBN with and without CBD on sleep quality Study
    Experimental and Clinical Psychopharmacology / PubMed (PMID: 37796540)(2024)— Randomisierte klinische Studie mit 293 Personen zur isolierten und kombinierten Gabe von Cannabinol (CBN) und Cannabidiol (CBD).
  7. Studie: Cannabidiol treatment in hand osteoarthritis and psoriatic arthritis: a randomized, double-blind, placebo-controlled trial Study
    Pain / PubMed (PMID: 34510141)(2022)— 12-wöchige klinische Untersuchung zur Schmerzwirkung von 20 bis 30 mg oralem CBD bei Arthrose-Patienten.
  8. Übersicht: The safety and efficacy of low oral doses of cannabidiol: An evaluation of the evidence Study
    Clinical and Translational Science / PubMed (PMID: 36259271)(2023)— Systematischer Review zur Wirksamkeit und Verträglichkeit frei verkäuflicher Niedrigdosis-CBD-Produkte.

Frequently Asked Questions (FAQ)

Does CBD oil get you high?
Pure CBD usually does not cause the high typical of THC. However, full-spectrum products may contain traces of THC. Product analyses are therefore particularly important.
Can CBD cause interactions with medications?
Yes. CBD can affect liver enzymes involved in the breakdown of various medications. If you take medication regularly, CBD should only be used after consulting a doctor or pharmacist.
Can CBD oil help with pain?
While individuals report positive experiences, controlled studies so far do not confirm a reliable pain-relieving effect of CBD alone.
Legal Notice

This article is provided for general informational purposes only and does not constitute legal, tax or medical advice. For individual questions, please consult a qualified professional. Laws and regulations may change – please always check the currently applicable legal requirements.

Cannabis Expert at CANNANA

Maryna K.

Maryna K. has been dedicated to cannabis, CBD, and other hemp products out of personal conviction for many years. Her interest began through her own positive experiences in everyday life. Since then, she has studied the properties of the hemp plant and its diverse applications in depth.

Maryna has been part of CANNANA since its founding and now works full-time with cannabis and cannabinoids. She closely follows current industry developments, attends trade fairs, exchanges insights with industry representatives, and regularly stays informed about new cannabinoids, product developments, and scientific publications on CBD.

As an author and editorial lead at CANNANA, she writes guide articles on CBD, THC, terpenes, hemp products, and cannabis-related topics. Her goal is to explain complex relationships clearly, put new findings into context, and provide readers with well-founded guidance.

Breaking down prejudices against cannabis is especially important to Maryna. Convinced of the potential of the hemp plant, she advocates for an objective, open, and informed approach to the topic. In doing so, she combines personal experience, practical insights, and scientific findings without making unsubstantiated health claims.
All articles by Maryna K.

You might also be interested in

View all guides →
CBDCBD Vape Guide 2026: Was bringt CBD Vapen, wie wirkt es und welches Gerät ist das beste?
CBDCBD-Blüten richtig lagern: So bleiben Aroma und Qualität erhalten
CBDAutofahren nach CBD: Darf man mit CBD Öl, Blüten & Vapes ans Steuer? Rechtslage 2026

Reading next

Autofahren nach CBD: Darf man mit CBD Öl, Blüten & Vapes ans Steuer? Rechtslage 2026
Welche Cannabis-Produkte eignen sich am besten für Anfänger?